Quantinno Capital Management LP Takes Position in Phreesia, Inc. $PHR

Quantinno Capital Management LP acquired a new position in shares of Phreesia, Inc. (NYSE:PHR) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 69,879 shares of the company’s stock, valued at approximately $586,000. Quantinno Capital Management LP owned approximately 0.12% of Phreesia as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Van ECK Associates Corp raised its position in shares of Phreesia by 78.7% during the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after purchasing an additional 1,102 shares during the period. New York State Teachers Retirement System purchased a new position in Phreesia in the 1st quarter worth about $44,000. Rockefeller Capital Management L.P. increased its stake in Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after purchasing an additional 2,149 shares in the last quarter. KBC Group NV raised its holdings in Phreesia by 83.4% during the 4th quarter. KBC Group NV now owns 3,449 shares of the company’s stock worth $58,000 after buying an additional 1,568 shares during the period. Finally, Garner Asset Management Corp acquired a new stake in Phreesia during the 4th quarter worth about $81,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Trading Up 4.8%

Shares of NYSE PHR opened at $11.99 on Thursday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41. Phreesia, Inc. has a one year low of $7.77 and a one year high of $32.76. The business has a 50-day moving average price of $10.66 and a two-hundred day moving average price of $10.53. The firm has a market capitalization of $741.35 million, a PE ratio of 79.96 and a beta of 0.85.

Phreesia (NYSE:PHR) last issued its earnings results on Wednesday, May 27th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The company had revenue of $130.94 million for the quarter, compared to the consensus estimate of $130.08 million. During the same quarter in the prior year, the company earned ($0.07) EPS. The firm’s quarterly revenue was up 12.9% on a year-over-year basis. As a group, analysts predict that Phreesia, Inc. will post 0.39 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on PHR. Piper Sandler cut shares of Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 target price for the company. in a report on Thursday, May 28th. Wells Fargo & Company restated an “equal weight” rating and set a $9.00 price target (down from $15.00) on shares of Phreesia in a report on Wednesday, May 20th. Barclays restated an “equal weight” rating and issued a $10.00 price target (down from $24.00) on shares of Phreesia in a research report on Thursday, May 14th. Canaccord Genuity Group decreased their price objective on shares of Phreesia from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Thursday, May 28th. Finally, Citigroup reiterated a “market perform” rating on shares of Phreesia in a research report on Friday, May 29th. Nine research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Phreesia presently has an average rating of “Hold” and a consensus price target of $16.65.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.